Moore Capital Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Hold
0
410
2023
Q3
Hold
0
430
2023
Q2
Hold
0
482